Ebola: vaccine trials can offer ‘signs of hope’ says UN health chief

UNITED NATIONS NEWS CENTRE                                Jan. 8, 2015

GENEVA--The United Nations World Health Organization (WHO) today convened in Geneva its second ever high-level meeting on Ebola vaccines access and financing, to review the current status of clinical trials and plans for Phase II and Phase III efficacy trials.

WHO mobile lab scientists at the crossing point between Guinea and Sierra Leone, two of the countries affected by the Ebola outbreak in West Africa. Photo: WHO/Saffea Gborie

“We are here to take stock, plan the next steps, and make sure that all partners are working in tandem. We all want the momentum and sense of urgency to continue,” Dr. Margaret Chan, Director-General of WHO said as she kicked off the meeting.

The most advanced candidate Ebola vaccine is scheduled to enter Phase III efficacy clinical trials in West Africa in January/February 2015, and if shown effective – will be available for deployment a few months later.

Participating in today’s discussions were representatives from manufacturers and research institutions, currently developing or testing Ebola candidate vaccines, Government officials from the Ebola-affected and neighbouring countries, and non-governmental organizations and partners.

http://www.un.org/apps/news/story.asp?NewsID=49756#.VK85uXu1f8w